Patents by Inventor Xuejun Luo

Xuejun Luo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240122982
    Abstract: A chimeric antigen receptor fusion protein co-expressing IL-7 and CCR2b, and application thereof are provided. The fusion protein includes a chimeric antigen receptor, a 2A peptide, IL-7, a 2A peptide and CCR2b which are sequentially linked in series.
    Type: Application
    Filed: March 30, 2021
    Publication date: April 18, 2024
    Inventors: Guangchao LI, Min LUO, Wen DING, Xuejun WANG
  • Patent number: 10071989
    Abstract: The present invention relates to substituted cinnamamide derivatives, the method for preparing thereof and the use thereof. Each of said derivatives has a structure of formula (I). The method for preparing the substituted cinnamamides and their derivatives of the present invention is also disclosed. Substituted piperonal derivatives are selected as starting materials to prepare the substituted cinnamamide derivatives of the present invention by Wittig reaction and acid-amine condensation reaction. Further, a use of the present compounds in preventing and treating depressive-type mental diseases is disclosed.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: September 11, 2018
    Assignee: TASLY PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Xiaohui Ma, Yuanpeng Jin, Min Han, Shuiping Zhou, Wangyi Zhou, Xuejun Luo, Guocheng Wang, Lulu Yan, Lanlan Zhang, Yonghong Zhu
  • Publication number: 20140121242
    Abstract: The present invention relates to substituted cinnamamide derivatives, the method for preparing thereof and the use thereof. Each of said derivatives has a structure of formula (I). The method for preparing the substituted cinnamamides and their derivatives of the present invention is also disclosed. Substituted piperonal derivatives are selected as starting materials to prepare the substituted cinnamamide derivatives of the present invention by Wittig reaction and acid-amine condensation reaction. Further, a use of the present compounds in preventing and treating depressive-type mental diseases is disclosed.
    Type: Application
    Filed: June 26, 2012
    Publication date: May 1, 2014
    Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Xiaohui Ma, Yuanpeng Jin, Min Han, Shuiping Zhou, Wangyi Zhou, Xuejun Luo, Guocheng Wang, Lulu Yan, Lanlan Zhang, Yonghong Zhu
  • Publication number: 20120041062
    Abstract: The present invention relates to a new compound of salvianolic acid L, its preparation method, a pharmaceutical composition containing the salvianolic acid L, and its use for preparing a medicament for treating cardio-cerebrovascular diseases.
    Type: Application
    Filed: March 29, 2010
    Publication date: February 16, 2012
    Applicant: Tianjin Tasly Pharmaceutical Co., Ltd.
    Inventors: Shuiping Zhou, Wei Li, Yuanpeng Jin, Xiaohui Ma, Jianping Han, Hongfang Cui, Xuejun Luo, Xiaopeng Chen